A new study led by Rutgers clinician and researcher Mark Einstein is examining a revolutionary way to block transmission of human papillomavirus (HPV), the organism that causes 99 percent of cervical cancers, using a topical gel applied during sexual activity.
Twenty percent of women have the same strain as well, and 45 percent of men have some kind of genital HPV, according to new data from the National Center for Health Statistics.
More than 12,000 women are diagnosed with cervical cancer each year in the USA, and more than 4,000 of them will die of it. HPV is also linked to cancers of the vagina, vulva, penis, anus, and back of the throat, tongue and tonsils, in men and women.
Human papillomaviruses are a group of more than 150 related viruses that infect different parts of the body.
Scientists hope the drop in HPV cases will lead to a significant drop in future cervical cancer cases.
"The next step is to increase awareness of the high prevalence of high-risk genital and oral HPV in our general U.S. population so individuals will realize that this is a serious problem and they will get their children vaccinated in early adolescence before they become sexually active", McQuillan said.
The CDC recommends that children receive the HPV vaccine around age 11 or 12 so that they become protected before potential exposure to the virus through sexual contact. Please support our efforts.More news: McConnell starts clock on Neil Gorsuch nuclear showdown
More news: Obama aide says intel not used to spy on Trump advisers
More news: S. Korean ambassador to return
"After the introduction of the HPV vaccine in 2006, there has been a decrease in genital HPV in young adults - this is a vaccine against cancer", she said.
While great progress has been made in creating HPV vaccines, current approaches to prevent infection have limitations.
The report published by the CDC also addressed the oral HPV infections among adults.
The survey also showed that men were the most affected by HPV when compared to women, while black people were considerably more affected when compared to other ethnic and racial groups. Though recent numbers have shown high HPV rates, vaccinating adolescents has been the proven way to bring these totals down. The CDC recommends the HPV vaccine for young women through the age of 26, and for young men through 21.
Wyand added that "HPV immunization is a sparkling triumph of public health".
Electra Paskett, a cancer control researcher at the Ohio State University Comprehensive Cancer Center, pointed out that there's still a lack of urgency among parents to get their children vaccinated. "It is a cancer vaccine", Paskett said.
Dr. Lois Ramondetta, a professor of gynecologic oncology at MD Anderson Cancer Center in Texas, told NBC News previous year: "There is an epidemic of HPV related cancers in men, specifically those of the tonsil and the back of the tongue. It is important that we share this good news to encourage continued participation in this successful programme". Our role as an independent, fact-based news organization has never been clearer.